Idiopathic Inflammatory Myopathy - 23 Studies Found
| Not yet recruiting |
: Study of Arimoclomol in Inclusion Body Myositis (IBM) : Inclusion Body Myositis : 2016-04-25 :
|
| Completed |
: Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis : Inclusion Body Myositis : 2009-05-11 |
| Active, not recruiting |
: An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203 : Sporadic Inclusion Body Myositis : 2015-07-09 :
|
| Completed |
: Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis : Inclusion Body Myositis : 2008-12-04 : Drug: Etanercept 50 milligrams subcutaneously every week |
| Active, not recruiting |
: Natalizumab in Inclusion Body Myositis (IBM) : Inclusion Body Myositis (IBM) : 2013-05-31 : Drug: Natalizumab Other Name: Tysabri |
| Completed |
: Blood-flow Restricted Exercise in Inclusion Body Myositis : Sporadic Inclusion Body Myositis : 2014-12-10 :
|
| Completed |
: Treatment With TNF Blockade, Infliximab, in Patients With Myositis : Refractory Myositis : 2007-03-02 : Drug: Infliximab |
| Completed |
: Immune Abnormalities in Sporadic Inclusion Body Myositis :
|
| Recruiting |
: Adult and Juvenile Myositis :
|